Skip to content

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

News

Select Year
Clinical Trials
Search …

January 21, 2010

Media Advisory – Oncolytics Biotech(R) Inc. to Present at BioPartnering North America

December 11, 2009

Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development

December 2, 2009

Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters’ Over-Allotment Option

November 23, 2009

Oncolytics Biotech(R) Inc. Closes US$12.75 Million Unit Offering

November 18, 2009

Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering

November 17, 2009

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting

November 17, 2009

Oncolytics Biotech(R) Inc. Announces Unit Offering

November 16, 2009

Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting

November 6, 2009

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting

November 5, 2009

Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results

Page 57 of 71

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

Our Mission
Leadership
Board of Directors
Careers
Contact

Science

Our Science
Pipeline
Resources

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Manage Consent

Copyright © 2026 Oncolytics Biotech Inc.